Ligand validation:6PA3

ASN: ASPARAGINE

ASN is a Ligand Of Interest in 6PA3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PA3_ASN_C_401	99%	41%	0.047	0.976	1.2	1.14	1	1	0	0	100%	1
6PA3_ASN_A_401	97%	67%	0.063	0.98	0.79	0.48	-	-	0	0	100%	1
6PA3_ASN_D_401	97%	54%	0.067	0.98	1.43	0.37	1	-	0	0	100%	1
6PA3_ASN_B_401	95%	48%	0.067	0.972	1.35	0.68	1	-	0	0	100%	1
6PA5_ASN_H_401	98%	67%	0.056	0.979	0.41	0.84	-	-	0	0	100%	1
6PA6_ASN_C_401	97%	69%	0.058	0.973	0.98	0.22	-	-	0	0	100%	1
6PA8_ASN_C_401	97%	68%	0.066	0.981	0.33	0.86	-	-	0	0	100%	1
5DNC_ASN_C_601	95%	54%	0.063	0.969	1.02	0.75	-	-	0	0	100%	1
4M65_ASN_A_420	95%	28%	0.063	0.968	1.88	1.17	2	1	2	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.